Search

everythinglearnresearchcommunity

for

Search:↓

Genetic screening for NUDT15 polymorphisms is crucial for patients taking azathioprine, especially in Asians.

PX-12 may help treat psoriasis by blocking inflammation and cell death.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Ritlecitinib may help young adults with severe alopecia areata when ketoconazole doesn't work.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

Gefitinib can cause slower, finer, brittle, and curly scalp hair.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.

The document's conclusion cannot be provided because the document is not available or cannot be read.

Isoxazole 9 (ISX9) may help regrow hair by activating certain cell signals.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.

JAK inhibitors show promise in treating difficult skin diseases.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

Ritlecitinib is effective and safe for treating severe alopecia areata, showing significant hair regrowth and improved mental health.

Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.

Dupilumab significantly improved a 5-year-old girl's prurigo nodularis without side effects.

Sorafenib and Platycladus orientalis leaf extract together effectively suppress cervical cancer cell growth.

Tofacitinib helps hair regrow in some kids with severe alopecia areata, but more research is needed on long-term effects.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.